Clinical & Regulatory Strategy
Strategic clinical and regulatory guidance to evaluate development pathways, strengthen evidence strategies, and support critical product development decisions.
Strategic clinical and regulatory guidance to evaluate development pathways, strengthen evidence strategies, and support critical product development decisions.
CIMI works with medical device, diagnostic, and life sciences organizations to assess clinical and regulatory strategies, evaluate study plans and evidence needs, and identify potential risks or gaps that may affect product development. Our focus is helping organizations understand their options, strengthen their approach, and make informed decisions about the path forward.
Clinical Development Strategy & Planning
Strategic guidance to evaluate clinical development plans, study design approaches, and evidence needs in alignment with product and regulatory objectives.
- Clinical development strategy
- Study design assessment
- Endpoint & objective strategy review
- Evidence needs assessment
- Clinical feasibility considerations
Protocol & Clinical Documentation Strategy
Strategic review of protocols and clinical documentation to assess alignment with study objectives, evidence needs, and regulatory expectations.
- Protocol strategy review
- Schedule of assessments review
- Clinical document assessment
- Data collection strategy review
- Cross-functional document alignment
Clinical Program Advisory
Senior-level clinical perspective to assess program execution, identify risks and gaps, and provide strategic guidance throughout clinical development.
- Clinical program assessment
- Study risk & gap identification
- Development decision support
- CRO & vendor strategy and oversight
- Study rescue & remeditation strategy
Risk-Based Strategy
Strategic assessment of clinical study risks and oversight needs to support study quality, operational effectiveness, and informed decision-making.
- Risk assessment & prioritization
- Oversight strategy review
- Quality-focused study review
- Operational risk identification
- Escalation & mitigation planning
Site & Investigator Strategy
Strategic assessment of site and investigator considerations to support study feasibility, performance, and clinical execution.
- Site strategy assessment
- Investigator considerations
- Site performance review
- Enrollment risk assessment
- Site & study feasibility insights
Data Integrity & Quality Planning
Strategic review of clinical data and quality considerations to identify risks, strengthen study processes, and support reliable evidence generation.
- Data quality strategy review
- Clinical data considerations
- Documentation & process assessment
- Data completeness & consistency review
- Clinical evidence integrity assessment
Experience. Perspective. Strategic Clarity.
Bring greater clarity to your clinical and regulatory strategy.
Schedule a strategic clinical discussion.